Journal of the American Academy of Dermatology 2013-12-01

Emerging therapies in rosacea.

Alison Layton, Diane Thiboutot

Index: J. Am. Acad. Dermatol. 69(6 Suppl 1) , S57-65, (2013)

Full Text: HTML

Abstract

Rosacea is a common skin disorder with multiple symptoms. The emergence of research that furthers understanding of pathophysiological mechanisms has created new targets for disease treatment. Specifically, there is a need for new treatments that address the various erythematic symptoms associated with rosacea. Systemic and topical therapies have both yielded positive results in treating rosacea with various medications. Subantimicrobial-dose doxycycline is one such promising treatment. Development of novel products in the near future should help achieve more satisfactory outcomes for patients. Copyright © 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Related Compounds

  • Permethrin
  • trans-permethrin
  • cis-Permethrin St...
  • Doxycycline hyclat...
  • Ivermectin

Related Articles:

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

2010-01-01

[Chem. Res. Toxicol. 23 , 171-83, (2010)]

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

2011-12-01

[J. Sci. Ind. Res. 65(10) , 808, (2006)]

Developing structure-activity relationships for the prediction of hepatotoxicity.

2010-07-19

[Chem. Res. Toxicol. 23 , 1215-22, (2010)]

A predictive ligand-based Bayesian model for human drug-induced liver injury.

2010-12-01

[Drug Metab. Dispos. 38 , 2302-8, (2010)]

Atmospheric pressure gas chromatography-time-of-flight-mass spectrometry (APGC-ToF-MS) for the determination of regulated and emerging contaminants in aqueous samples after stir bar sorptive extraction (SBSE).

2014-12-03

[Anal. Chim. Acta 851 , 1-13, (2014)]

More Articles...